Your browser doesn't support javascript.
loading
CYAD-01, an autologous NKG2D-based CAR T-cell therapy, in relapsed or refractory acute myeloid leukaemia and myelodysplastic syndromes or multiple myeloma (THINK): haematological cohorts of the dose escalation segment of a phase 1 trial.
Sallman, David A; Kerre, Tessa; Havelange, Violaine; Poiré, Xavier; Lewalle, Philippe; Wang, Eunice S; Brayer, Jason B; Davila, Marco L; Moors, Ine; Machiels, Jean-Pascal; Awada, Ahmad; Alcantar-Orozco, Erik M; Borissova, Rossitza; Braun, Nathalie; Dheur, Marie-Sophie; Gilham, David E; Lonez, Caroline; Lehmann, Frédéric F; Flament, Anne.
Afiliação
  • Sallman DA; Department of Malignant Hematology, H Lee Moffitt Cancer Center, Tampa, FL, USA. Electronic address: david.sallman@moffitt.org.
  • Kerre T; Department of Hematology, Gent University Hospital, Ghent, Belgium.
  • Havelange V; Department of Cancerology and Hematology, Institut Roi Albert II, Cliniques Universitaires Saint-Luc, UCLouvain, Brussels, Belgium.
  • Poiré X; Department of Cancerology and Hematology, Institut Roi Albert II, Cliniques Universitaires Saint-Luc, UCLouvain, Brussels, Belgium.
  • Lewalle P; Laboratory of Experimental Hematology, Institut Jules Bordet (ULB), Brussels, Belgium.
  • Wang ES; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Brayer JB; Department of Malignant Hematology, H Lee Moffitt Cancer Center, Tampa, FL, USA.
  • Davila ML; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Moors I; Department of Hematology, Gent University Hospital, Ghent, Belgium.
  • Machiels JP; Department of Cancerology and Hematology, Institut Roi Albert II, Cliniques Universitaires Saint-Luc, UCLouvain, Brussels, Belgium.
  • Awada A; Laboratory of Experimental Hematology, Institut Jules Bordet (ULB), Brussels, Belgium.
  • Alcantar-Orozco EM; Celyad Oncology, Mont-Saint-Guibert, Belgium.
  • Borissova R; Celyad Oncology, Mont-Saint-Guibert, Belgium.
  • Braun N; Celyad Oncology, Mont-Saint-Guibert, Belgium.
  • Dheur MS; Celyad Oncology, Mont-Saint-Guibert, Belgium.
  • Gilham DE; Celyad Oncology, Mont-Saint-Guibert, Belgium.
  • Lonez C; Celyad Oncology, Mont-Saint-Guibert, Belgium.
  • Lehmann FF; Celyad Oncology, Mont-Saint-Guibert, Belgium.
  • Flament A; Celyad Oncology, Mont-Saint-Guibert, Belgium.
Lancet Haematol ; 10(3): e191-e202, 2023 Mar.
Article em En | MEDLINE | ID: mdl-36764323
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mieloide Aguda / Mieloma Múltiplo Limite: Humans Idioma: En Revista: Lancet Haematol Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mieloide Aguda / Mieloma Múltiplo Limite: Humans Idioma: En Revista: Lancet Haematol Ano de publicação: 2023 Tipo de documento: Article